Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CAPR

CAPR News

Newswire

15:01

Capricor: Maxim Group Raises Buy Rating, PT to $50 from $25

09:30

Capricor Therapeutics, Inc. shares rise over 370.0%, currently trading at $29.96

06:47

Capricor Therapeutics' stock drops 8.4% after significant surge in previous session.

20:04

HC Wainwright Raises CAPR Price Target to $60, Maintains Buy Rating

20:04

Capricor Therapeutics: Deramiocel Trial Shows Strong Results for Duchenne Muscular Dystrophy Treatment

View More

About CAPR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More